VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OMOutset Medical, Inc.
$4.79$89M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOMQuarterly Financials

Outset Medical, Inc. (OM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Outset Medical, Inc. (OM) quarterly income statement — complete revenue, gross profit & net income history

OM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue27.86M28.87M29.43M31.42M29.75M29.47M28.67M27.39M28.17M30.51M30.36M36.04M33.47M32.01M27.76M25.06M30.55M28.15M26.32M25.22M
Revenue Growth %-6.35%-2.01%2.67%14.72%5.62%-3.41%-5.59%-24.01%-15.83%-4.69%9.37%43.83%9.55%13.69%5.48%-0.63%33.31%63.23%91.32%114.75%
Cost of Goods Sold15.77M16.64M17.84M19.55M18.69M18.72M18.85M17.61M19.95M22.8M23.2M28.34M27.04M26.73M23.43M21.27M26.11M24.83M23.37M24.16M
COGS % of Revenue56.59%57.64%60.62%62.23%62.81%63.53%65.74%64.28%70.84%74.72%76.43%78.63%80.79%83.53%84.38%84.91%85.46%88.2%88.81%95.83%
Gross Profit12.1M12.23M11.59M11.87M11.07M10.75M9.82M9.78M8.21M7.71M7.16M7.7M6.43M5.27M4.34M3.78M4.44M3.32M2.95M1.05M
Gross Margin %43.41%42.36%39.38%37.77%37.19%36.47%34.26%35.72%29.16%25.28%23.57%21.37%19.21%16.47%15.62%15.09%14.54%11.8%11.19%4.17%
Gross Profit Growth %9.3%13.81%18.02%21.31%34.7%39.35%37.21%26.99%27.8%46.25%65.06%103.68%44.71%58.78%47.18%259.51%1437.02%696.4%157.47%122.08%
Operating Expenses29.01M29.57M27.4M28.73M27.46M32.61M33.66M40.55M45.13M45.06M52.61M51.18M49.91M45.1M45.34M47.5M40.92M44.12M33.08M30.96M
OpEx % of Revenue104.13%102.43%93.11%91.45%92.31%110.66%117.42%148.04%160.21%147.72%173.28%142.01%149.14%140.9%163.3%189.58%133.93%156.72%125.71%122.77%
Selling, General & Admin23.4M24.8M22.03M23.44M21.95M24.72M25.52M30.81M32.49M32.53M36.53M36.27M36.12M33.65M32.28M33.98M30.09M32.71M23.36M22.93M
SG&A % of Revenue83.97%85.91%74.84%74.61%73.78%83.88%89.03%112.5%115.35%106.64%120.33%100.65%107.93%105.14%116.26%135.62%98.48%116.19%88.74%90.92%
Research & Development5.62M5.05M5.38M5.29M5.51M7.89M8.14M9.73M12.63M12.53M16.08M14.91M13.79M11.44M13.06M13.52M10.83M11.41M9.73M8.03M
R&D % of Revenue20.16%17.5%18.27%16.83%18.54%26.77%28.39%35.54%44.86%41.08%52.95%41.36%41.21%35.75%47.04%53.96%35.45%40.53%36.97%31.85%
Other Operating Expenses0-284K000000000000000000
Operating Income-16.92M-17.34M-15.81M-16.86M-16.4M-21.86M-23.84M-30.76M-36.91M-37.35M-45.45M-43.48M-43.48M-39.82M-41M-43.72M-36.48M-40.8M-30.14M-29.91M
Operating Margin %-60.72%-60.07%-53.73%-53.68%-55.12%-74.18%-83.16%-112.33%-131.04%-122.44%-149.71%-120.64%-129.93%-124.42%-147.69%-174.49%-119.39%-144.92%-114.51%-118.6%
Operating Income Growth %-3.17%20.66%33.67%45.18%55.57%41.48%47.55%29.24%15.12%6.2%-10.87%0.56%-19.22%2.39%-36.04%-46.19%-22.91%-29.05%26.01%-20.06%
EBITDA-16.92M-16.46M-15.49M-15.71M-15.11M-20.45M-21.69M-29.29M-35.45M-35.91M-43.67M-41.66M-41.81M-38.27M-39.4M-42.12M-34.94M-39.24M-28.57M-28.35M
EBITDA Margin %-60.72%-57.02%-52.63%-50%-50.77%-69.41%-75.66%-106.96%-125.86%-117.7%-143.84%-115.58%-124.92%-119.56%-141.94%-168.1%-114.38%-139.39%-108.55%-112.42%
EBITDA Growth %-12.01%19.51%28.58%46.37%57.39%43.04%50.33%29.68%15.2%6.17%-10.83%1.11%-19.64%2.48%-37.93%-48.59%-24%-32.19%29.11%-16.09%
D&A (Non-Cash Add-back)0881K322K1.16M1.29M1.41M2.15M1.47M1.46M1.45M1.78M1.82M1.68M1.56M1.6M1.6M1.53M1.56M1.57M1.56M
EBIT-16.92M-17.34M-13.96M-16.86M-16.41M-19.82M-21.69M-28.29M-33.81M-35.07M-42.88M-40.81M-40.84M-39.28M-40.19M-43.26M-36.35M-40.68M-30.04M-29.74M
Net Interest Income3.37M-1.77M-1.62M-1.57M-1.58M-3.78M-3.92M-3.54M-2.87M-1.14M-640K-435K-294K-189K238K-22K-302K-308K-332K-267K
Interest Income01.67M1.85M1.9M1.98M2.04M2.15M2.47M3.1M2.28M2.57M2.67M2.65M1.91M805K459K120K123K99K164K
Interest Expense-3.37M3.44M3.48M3.48M3.56M5.83M6.07M6.01M5.97M3.42M3.21M3.1M2.94M2.1M567K481K422K431K431K431K
Other Income/Expense-1.84M-2.05M-1.62M-1.57M-9.27M-3.78M-3.92M-3.54M-2.87M-1.14M-640K-435K-294K-1.56M238K-22K-302K-308K-332K-267K
Pretax Income-18.76M-19.4M-17.43M-18.44M-25.67M-25.64M-27.76M-34.3M-39.78M-38.49M-46.09M-43.91M-43.78M-41.38M-40.76M-43.74M-36.78M-41.11M-30.47M-30.17M
Pretax Margin %-67.33%-67.17%-59.24%-58.68%-86.27%-87.02%-96.83%-125.25%-141.23%-126.16%-151.81%-121.85%-130.81%-129.28%-146.83%-174.57%-120.38%-146.02%-115.78%-119.66%
Income Tax217K95K404K104K115K-4K182K151K162K112K86K133K192K64K20K96K115K125K035K
Effective Tax Rate %-1.16%-0.49%-2.32%-0.56%-0.45%0.02%-0.66%-0.44%-0.41%-0.29%-0.19%-0.3%-0.44%-0.15%-0.05%-0.22%-0.31%-0.3%0%-0.12%
Net Income-18.98M-19.49M-17.84M-18.54M-25.78M-25.64M-27.94M-34.45M-39.94M-38.6M-46.18M-44.05M-43.97M-41.44M-40.78M-43.84M-36.89M-41.23M-30.47M-30.21M
Net Margin %-68.11%-67.5%-60.61%-59.01%-86.66%-87.01%-97.47%-125.8%-141.81%-126.53%-152.1%-122.21%-131.39%-129.48%-146.9%-174.96%-120.76%-146.46%-115.78%-119.8%
Net Income Growth %26.39%23.98%36.16%46.19%35.45%33.58%39.5%21.78%9.16%6.86%-13.24%-0.47%-19.19%-0.51%-33.84%-45.12%-22.87%-28.68%27.96%-13.97%
Net Income (Continuing)-18.98M-19.49M-17.84M-18.54M-25.78M-25.64M-27.94M-34.45M-39.94M-38.6M-46.18M-44.05M-43.97M-41.44M-40.78M-43.84M-36.89M-41.23M-30.47M-30.21M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.03-1.09-1.00-1.04-7.44-7.35-8.30-9.96-11.77-0.77-0.93-0.90-0.90-0.86-0.85-0.92-0.78-0.87-0.65-0.66
EPS Growth %86.16%85.17%87.95%89.56%36.79%-854.55%-792.47%-1006.67%-1207.78%10.47%-9.41%2.17%-15.38%1.15%-30.77%-39.39%-11.43%-16%36.89%1.49%
EPS (Basic)-1.03-1.09-1.00-1.04-7.44-7.35-8.30-9.96-11.77-0.77-0.93-0.90-0.90-0.86-0.85-0.92-0.78-0.88-0.65-0.66
Diluted Shares Outstanding18.37M17.82M17.78M17.74M3.46M3.42M3.37M3.46M3.39M3.35M3.33M3.26M3.25M3.23M3.21M3.19M3.17M3.14M3.11M3.05M
Basic Shares Outstanding18.37M17.82M17.78M17.74M3.46M3.42M3.37M3.46M3.39M3.35M3.33M3.26M3.25M3.23M3.21M3.18M3.15M3.14M3.11M3.05M
Dividend Payout Ratio--------------------